Acquiring Company
Dr. Lal PathLabs Limited
Acquired Company
SN Genelab Private Limited
Dubai Emirate
GujaratBiotechnologyHealth CareMedicalHealth DiagnosticsBiotechnologyHealth CareGeneticsHealth DiagnosticsDescription
Dr Lal PathLabs has announced its acquisition of a 70% stake in SN Genelab for up to ₹168 crore. The transaction, expected to close by November 30, 2026, will enhance Dr Lal PathLabs' capabilities in genomics. SN Genelab will become a subsidiary of Dr Lal PathLabs following the acquisition. This strategic move aims to broaden Dr Lal PathLabs' advanced diagnostic services portfolio.
Quick answer
Dr. Lal PathLabs Limited is acquiring SN Genelab Private Limited, announced September 24, 2026. Dr. Lal PathLabs Limited is based in Dubai Emirate, United Arab Emirates.
- How much did Dr. Lal PathLabs Limited pay for SN Genelab Private Limited?
- The deal value was not disclosed.
- What does Dr. Lal PathLabs Limited do?
- Dr. Lal PathLabs Limited is one of India's leading diagnostic chains, specializing in providing top-notch diagnostic services across the country.
- Where are Dr. Lal PathLabs Limited and SN Genelab Private Limited based?
- Dr. Lal PathLabs Limited is based in Dubai Emirate, United Arab Emirates. SN Genelab Private Limited is based in Gujarat, India.
- Who are the decision-makers at Dr. Lal PathLabs Limited?
- Fundz holds 2 contacts at Dr. Lal PathLabs Limited. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Medical and Health Diagnostics
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Veracyte, Inc. acquires Convergent Genomics Inc. (September 14, 2026)
- Cent acquires AI radiology platform Medsee (October 27, 2026)
- Integral Diagnostics successfully merges with Capitol Health (August 25, 2026)
- Vantive Enters Agreement to Divest Majority of Hemodialysis Assets to Rockwell Medical to Focus on Home Dialysis. (November 4, 2026)
- Rockwell Medical, Inc. to Acquire Vantive Limited's Hemodialysis Business (November 3, 2026)
- Globus Medical acquires Synaptive Medical (November 3, 2026)
Who to call at Dr. Lal PathLabs Limited, and when
When Dr. Lal PathLabs Limited changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Dr. Lal PathLabs Limited raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Dr. Lal PathLabs Limited, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Dr. Lal PathLabs Limited. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Dr. Lal PathLabs Limited makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired SN Genelab Private Limited?
SN Genelab Private Limited was acquired by Dr. Lal PathLabs Limited, based in Dubai Emirate. The deal was reported on September 24, 2026. Dr. Lal PathLabs Limited is one of India's leading diagnostic chains, specializing in providing top-notch diagnostic services across the country. Dr. Lal PathLabs Limited is privately held and operates in Biotechnology.
When did Dr. Lal PathLabs Limited acquire SN Genelab Private Limited?
Dr. Lal PathLabs Limited's acquisition of SN Genelab Private Limited was reported on September 24, 2026. Dr Lal PathLabs has announced its acquisition of a 70% stake in SN Genelab for up to ₹168 crore. The transaction, expected to close by November 30, 2026, will enhance Dr Lal PathLabs' capabilities in genomics. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does SN Genelab Private Limited do?
SN Genelab Private Limited is a private limited company engaged in medical testing and diagnostics. It is known for providing various laboratory services to healthcare providers. Following the acquisition, it will operate as a subsidiary of Dr Lal PathLabs. It is privately held, operating in Biotechnology, and is based in Gujarat.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.